These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28894602)

  • 1. Methods to assess bioresorbable vascular scaffold devices behaviour after implantation.
    Pernigotti A; Moscarella E; Spitaleri G; Scardino C; Ishida K; Brugaletta S
    J Thorac Dis; 2017 Aug; 9(Suppl 9):S959-S968. PubMed ID: 28894602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.
    Gogas BD; King SB; Samady H
    Glob Cardiol Sci Pract; 2015; 2015(5):62. PubMed ID: 26925407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Imaging of Bioresorbable Coronary Scaffolds - A Review.
    van Ditzhuijzen NS; Ligthart JM; Bruining N; Regar E; van Beusekom HM
    Interv Cardiol; 2013 Mar; 8(1):23-35. PubMed ID: 29588747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IVUS-Guided Implantation of Bioresorbable Vascular Scaffolds for Very Late Paclitaxel Stent Thrombosis.
    Lin ZZ; Chang WT; Chiang CY; Chen ZC; Ku PM
    Acta Cardiol Sin; 2017 Jan; 33(1):92-95. PubMed ID: 28115812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography guidance during bioresorbable vascular scaffold implantation.
    Secco GG; Verdoia M; Pistis G; De Luca G; Vercellino M; Audo A; Parisi R; Reale M; Ballestrero G; Marino PN; Di Mario C
    J Thorac Dis; 2017 Aug; 9(Suppl 9):S986-S993. PubMed ID: 28894605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
    Tenekecioglu E; Serruys PW; Onuma Y; Costa R; Chamié D; Sotomi Y; Yu TB; Abizaid A; Liew HB; Santoso T
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1115-1130. PubMed ID: 28527768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.
    Blachutzik F; Achenbach S; Marwan M; Röther J; Tröbs M; Schneider R; Nef H; Weissner M; Schlundt C
    Cardiovasc Revasc Med; 2019 Jun; 20(6):485-491. PubMed ID: 30097188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.
    Serruys PW; Onuma Y; Garcia-Garcia HM; Muramatsu T; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Ormiston JA
    EuroIntervention; 2014 Mar; 9(11):1271-84. PubMed ID: 24291783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
    Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
    Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable Scaffolds: Contemporary Status and Future Directions.
    Peng X; Qu W; Jia Y; Wang Y; Yu B; Tian J
    Front Cardiovasc Med; 2020; 7():589571. PubMed ID: 33330651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
    Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial.
    Brugaletta S; Gomez-Lara J; Bruining N; Radu MD; van Geuns RJ; Thuesen L; McClean D; Koolen J; Windecker S; Whitbourn R; Oberhauser J; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    EuroIntervention; 2012 Jul; 8(3):352-8. PubMed ID: 22130182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries.
    Zeng Y; Tateishi H; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Nie S; Jonker H; Dijkstra J; Radu MD; Räber L; McClean DR; van Geuns RJ; Christiansen EH; Fahrni T; Koolen J; Onuma Y; Bruining N; Serruys PW
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1151-1161. PubMed ID: 28330651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
    Serruys PW; Ormiston J; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Chevalier B; Smits P; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Wasungu L; Ediebah D; Veldhof S; Onuma Y
    J Am Coll Cardiol; 2016 Feb; 67(7):766-76. PubMed ID: 26892411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds: Differences Between Early and Late Events.
    Gori T; Weissner M; Gönner S; Wendling F; Ullrich H; Ellis S; Anadol R; Polimeni A; Münzel T
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2363-2371. PubMed ID: 29216999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study.
    Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Tröbs M; Röther J; Schlundt C; Achenbach S; Hamm C; Nef H
    Heart Vessels; 2017 Jul; 32(7):781-789. PubMed ID: 28004176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.